CorVel Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

CorVel yıllık ortalama 13.1% oranında kazançlarını artırırken, Healthcare sektöründe kazançlar growing at 5.3% annual. Gelirler growing yılda ortalama 8.5% oranında artmaktadır. CorVel'in özkaynak karlılığı 28.8% ve net marjı 9.6%'dir.

Anahtar bilgiler

13.1%

Kazanç büyüme oranı

14.7%

EPS büyüme oranı

Healthcare Sektör Büyümesi8.5%
Gelir büyüme oranı8.5%
Özkaynak getirisi28.8%
Net Marj9.6%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Oct 22
Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Aug 27
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

Jul 30
Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

Jul 12
CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 25
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Apr 07
CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

Mar 19
Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Jan 10
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

Dec 23
The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

Dec 05
With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Oct 10
CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Sep 01
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

Jul 10
We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 11
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

Mar 24
If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Jan 06
A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

Dec 19
Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

Sep 21
CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Aug 25
We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

CorVel GAAP EPS of $0.94, revenue of $176M

Aug 02

Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Jun 23
Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

May 18
Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

Mar 21
CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Feb 14
With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Gelir ve Gider Dağılımı

CorVel nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGS:CRVL Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2484682830
30 Jun 2481778800
31 Mar 2479576770
31 Dec 2377475750
30 Sep 2375175730
30 Jun 2373369710
31 Mar 2371966740
31 Dec 2270468710
30 Sep 2269065710
30 Jun 2267066700
31 Mar 2264666680
31 Dec 2162062670
30 Sep 2159759670
30 Jun 2157655660
31 Mar 2155346640
31 Dec 2055443640
30 Sep 2056141640
30 Jun 2057242650
31 Mar 2059247650
31 Dec 1959647660
30 Sep 1959448650
30 Jun 1959548630
31 Mar 1959647630
31 Dec 1858844620
30 Sep 1858343620
30 Jun 1857139610
31 Mar 1855836590
31 Dec 1754835590
30 Sep 1753632570
30 Jun 1752831580
31 Mar 1751929570
31 Dec 1651328580
30 Sep 1650928580
30 Jun 1650529570
31 Mar 1650429580
31 Dec 1549727560
30 Sep 1549628560
30 Jun 1549527550
31 Mar 1549329540
31 Dec 1449131540
30 Sep 1448933540
30 Jun 1448534530
31 Mar 1447934520
31 Dec 1347134500

Kaliteli Kazançlar: CRVL yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: CRVL 'nin mevcut net kar marjları (9.6%) geçen yılın (10%) değerinden daha düşüktür.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: CRVL şirketinin kazancı son 5 yılda yılda 13.1% oranında arttı.

Büyüme Hızlandırma: CRVL 'un son bir yıldaki kazanç büyümesi ( 9.1% ) 5 yıllık ortalamasının ( 13.1% /yıl) altındadır.

Kazançlar vs. Sektör: CRVL geçen yılki kazanç büyümesi ( 9.1% ) Healthcare sektörünün 10.3% performansını geride bırakmadı.


Özkaynak Getirisi

Yüksek ROE: CRVL 'nin Özsermaye Getirisi ( 28.8% ) yüksek olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin